Latest Breaking News On - Dana pizzuti - Page 1 : comparemela.com

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Receives $58 42 Consensus Price Target from Brokerages

Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twelve research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month […]

Robertw bairdMarc wilsonDana pizzutiNews ratings for crinetics pharmaceuticals dailyArtal groupJanus henderson groupCrinetics pharmaceuticals incCantor fitzgeraldCrinetics pharmaceuticalsJennison associatesAnalyst recommendations for crinetics pharmaceuticalsPricet rowe associates incInstitutional investors weigh in on crinetics pharmaceuticalsMorgan stanleyCrinetics pharmaceuticals stock performanceSecurities exchange commission

Crinetics Pharmaceuticals (NASDAQ:CRNX) Given New $70 00 Price Target at Morgan Stanley

Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target increased by Morgan Stanley from $50.00 to $70.00 in a research note released on Thursday, Benzinga reports. They currently have an overweight rating on the stock. Several other equities research analysts have also recently commented on CRNX. Jonestrading increased their price objective on Crinetics Pharmaceuticals […]

United statesRobertw bairdDana pizzutiRichard scott struthersAnalyst recommendations for crinetics pharmaceuticalsCantor fitzgeraldPrincipal financial group incSecurities exchange commissionNews ratings for crinetics pharmaceuticals dailyMorgan stanleyMirae asset global investments coCrinetics pharmaceuticalsCrinetics pharmaceuticals stock performanceVictory capital management incCrinetics pharmaceuticals incFree report

HC Wainwright Reiterates Buy Rating for Crinetics Pharmaceuticals (NASDAQ:CRNX)

HC Wainwright Reiterates Buy Rating for Crinetics Pharmaceuticals (NASDAQ:CRNX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerRichard scott struthersDana pizzutiCrinetics pharmaceuticalsHighmark wealth managementCrinetics pharmaceuticals trading downNews ratings for crinetics pharmaceuticals dailySecurities exchange commissionChina universal asset management coCantor fitzgeraldInstitutional trading of crinetics pharmaceuticalsAnalyst recommendations for crinetics pharmaceuticalsCrinetics pharmaceuticals incCrinetics pharmaceuticals company profileFree reportModerate buy

Crinetics Pharmaceuticals (NASDAQ:CRNX) Rating Reiterated by JMP Securities

Crinetics Pharmaceuticals (NASDAQ:CRNX) Rating Reiterated by JMP Securities
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Matthewk fustPiper sandlerDana pizzutiCrinetics pharmaceuticalsVanguard group incJennison associatesNews ratings for crinetics pharmaceuticals dailyMorgan stanleyAnalyst recommendations for crinetics pharmaceuticalsCrinetics pharmaceuticals stock performanceCantor fitzgeraldSecurities exchange commissionEventide asset managementInstitutional investors weigh in on crinetics pharmaceuticalsInsider transactions at crinetics pharmaceuticalsCrinetics pharmaceuticals inc

E Fund Management Co Ltd Acquires 2,914 Shares of Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX)

E Fund Management Co Ltd Acquires 2,914 Shares of Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Dana pizzutiRichard scott struthersPiper sandlerCrinetics pharmaceuticalsMorgan stanleyJennison associatesQuarter for crinetics pharmaceuticalsVanguard group incCrinetics pharmaceuticals trading downSecurities exchange commissionInsider activity at crinetics pharmaceuticalsCrinetics pharmaceuticals profileE fund management coCrinetics pharmaceuticals incNews ratings for crinetics pharmaceuticals dailyEventide asset management